Rare disease research funding is limited but creative. Discover government grants, patient-led support, international alliances, networks, and emerging models driving progress for 7,000+ conditions.
Research, treatment development, and patient support in rare disease often depend on funding from governments, charities, foundations, and industry. This section explains how rare disease research is funded, how grant systems work, and how decisions are made about which projects receive support.
Articles cover research grants, fellowships, charity funding, venture investment, pharmaceutical partnerships, and public funding programmes, as well as the challenges rare diseases face when competing for limited resources. We also report on new funding announcements, major grant awards, policy changes, and initiatives that may affect research, clinical trials, or patient access to treatment.
Where relevant, we highlight organisations, foundations, and funding bodies, and signpost opportunities that may be relevant to researchers, clinicians, patient groups, and advocates. The aim is to provide clear, factual insight into the financial and policy landscape that shapes progress in rare disease.